The National Institute of Neurological Disorders and Stroke (NINDS), the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications to develop novel technologies for in vivo imaging.*
Significant advances in medical imaging technologies made in the past 25 years largely have focused on structural or anatomical imaging at the organ or tissue level. Now there is an opportunity to develop and integrate novel imaging technologies that exploit current knowledge of the genetic and molecular bases of various diseases. Molecular biological discoveries have great implications for prevention, detection, and targeted therapy.
Potential topics of research interest include: early disease detection; disease screening; imaging for diagnosis, staging, or monitoring the effects of therapy; image-guided biopsy, therapy, and interventional procedures; copies of prototypes imaging systems; and research resources, including development of software and related informatics methods that assist in more efficient delivery of imaging technologies for screening, diagnosis, and treatment for cancer and other diseases.
For more information, potential applicants should contact Dr. Daofen Chen, Program Director, Channels, Synapses and Circuits Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2131, Bethesda, MD 20892; telephone: 301-496-1917; fax: 301-402-1501; e-mail: email@example.com.
*For a more detailed description of this program announcement, please visit the NIH web site at: http://grants1.nih.gov/grants/guide/pa-files/PA-04-094.html.